Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
Bronwyn M. Gunn, Shuangyi Bai
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4328-4344
Open Access | Times Cited: 19

Showing 19 citing articles:

With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashidhar S. Jatiani, Leonard Moise
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 2
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 13
Modulating antibody effector functions by Fc glycoengineering
Mikel García-Alija, Berre Van Moer, Diego E. Sastre, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108201-108201
Open Access | Times Cited: 12
Vaccinal effect of HIV-1 antibody therapy: dream or reality?
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 209-216
Closed Access | Times Cited: 7
Complement contributes to antibody-mediated protection against repeated SHIV challenge
Benjamin S. Goldberg, David A. Spencer, Shilpi Pandey, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 20
Open Access | Times Cited: 6
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
Gabriel Laghlali, Matthew Wiest, Dilara Karadag, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
Kahlio Mader, Lynn B. Dustin
Antibodies (2024) Vol. 13, Iss. 2, pp. 28-28
Open Access | Times Cited: 1
Beyond bnAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-neutralising Antibodies in Viral Infection
Kahlio Mader, Lynn B. Dustin
(2024)
Open Access | Times Cited: 1
Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers
Marita Helen Augustinussen, Garth D. Tylden, Christine Hanssen Rinaldo
Viruses (2023) Vol. 15, Iss. 3, pp. 619-619
Open Access | Times Cited: 4
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
NIAID/SMB Workshop on Multiscale Modeling of Infectious and Immune-Mediated Diseases
Reed S. Shabman, Morgan Craig, Reinhard Laubenbacher, et al.
Bulletin of Mathematical Biology (2024) Vol. 86, Iss. 5
Open Access
Defining correlates of protection for mammalian livestock vaccines against high-priority viral diseases
Samantha K. Davis, Jia Fan, Quentin G. Wright, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody
Dafna M. Abelson, Jennifer Barajas, Lauren Stuart, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_7, pp. S701-S711
Open Access | Times Cited: 1
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection
Cody J. Lauritsen, Ivy V. Trinh, Srushti P. Desai, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100189-100189
Open Access | Times Cited: 1
Anti-SARS-Cov-2 S-RBD IgG formed after BNT162b2 vaccination can bind C1q and activate complement
Anas H. A. Abu-Humaidan, Fatima Ahmad, Dima Awajan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement
Anas H. A. Abu-Humaidan, Fatima Ahmad, Dima Awajan, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 1
Expression of monoclonal antibodies for functional and structural studies
Vashti Irani, Caroline Soliman, Marcus A. Raftis, et al.
Methods in microbiology (2022), pp. 91-117
Closed Access
Special focus issue: passive immunization
Larry Zeitlin, Richard A. Cone
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 2
Open Access
Page 1

Scroll to top